Financial Troubles and Legal Issues for Abbott

This chapter focuses on Abbott's legal challenges surrounding its premature infant formula, with over 1,000 lawsuits in progress. Despite concerns, the CEO defends the product due to its importance in neonatal care. The episode also covers financial updates on Abbott's excellent earnings, the stock drop post-litigation news, troubles at Walgreens Boots Alliance, challenges at Charles Schwab, and clarifications on client cash handling in light of stock fluctuations.